Company research
Exascale Labs Holdings Inc.
CIK 2109869Updated Nov 10, 2026
Name history
D. Boral ARC Merger Corp · through Jul 7, 2026
XLAB price & chart
Loading TradingView…
NASDAQ:XLAB on TradingView ↗About the company
We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”). As such, we are eligible to take, have taken, and intend to take, advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
In the news
Recent filings
424B3 filing
Entry into a Material Definitive Agreement
Items 1.01, 9.01
EFFECT filing
424B3 filing
S-1 filing
Show 5 more recent filings
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Results of Operations and Financial Condition
Items 2.02, 9.01
Completion of Acquisition or Disposition of Assets
Items 2.01, 9.01
10-K filing
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 |
|---|---|
| ASSETS | |
| AssetsUSD | 6,726,725Source |
| Property, Plant and Equipment, NetUSD | 12,840Source |
| Current assets: | |
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,693,586Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 1,145,232Source |
| Assets, CurrentUSD | 6,523,885Source |
| LIABILITIES AND EQUITY | |
| LiabilitiesUSD | 31,885,500Source |
| Stockholders’ equity: | |
| Additional Paid in CapitalUSD | 220,636Source |
| Retained Earnings (Accumulated Deficit)USD | -25,379,426Source |
| Stockholders' Equity Attributable to ParentUSD | -25,158,775Source |
| Liabilities and EquityUSD | 6,726,725Source |
| Current liabilities: | |
| Liabilities, CurrentUSD | 31,885,500Source |
| Accounts Payable, CurrentUSD | 916,422Source |
| Additional Financial Items | |
| Accounts Receivable, after Allowance for Credit LossUSD | 1,107,210Source |
cash flow · annual statements
| Line item | FY 2026 |
|---|---|
| Cash flows from operating activities: | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -12,162,391Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 0Source |
| Changes in operating assets and liabilities: | |
| Increase (Decrease) in Accounts ReceivableUSD | 992,696Source |
| Increase (Decrease) in Accounts PayableUSD | 826,407Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -2,754,624Source |
| Cash flows from investing activities: | |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 1,406,521Source |
| Cash flows from financing activities: | |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -190,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,693,586Source |
| Additional Financial Items | |
| DepreciationUSD | 6,760Source |
| General and Administrative ExpenseUSD | 1,229,516Source |
| Net Income (Loss) Attributable to ParentUSD | -12,162,391Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -12,162,391Source |
| Operating ExpensesUSD | 7,219,093Source |
income statement · annual statements
| Line item | FY 2026 |
|---|---|
| Total RevenueUSD | 14,822,799Source |
| Cost of Goods and Services Sold | —Source |
| Operating Income (Loss)USD | -4,800,840Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -12,162,391Source |
| Net Income (Loss) Attributable to ParentUSD | -12,162,391Source |
| Earnings Per Share, BasicUSD per share | -8,108.26Source |
| Earnings Per Share, DilutedUSD per share | -8,108.26Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 1,500Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 1,500Source |
| Additional Financial Items | |
| General and Administrative ExpenseUSD | 1,229,516Source |
| Gross ProfitUSD | 2,418,253Source |
| Marketing and Advertising ExpenseUSD | 80,910Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -12,162,391Source |
| Operating ExpensesUSD | 7,219,093Source |
| Other IncomeUSD | 15,832Source |
| Research and Development ExpenseUSD | 5,490,185Source |
| Selling and Marketing ExpenseUSD | 499,392Source |
Offerings
Registration 333-299733
Filing attachments
exascalelabs_ex107.htm · S-1 · 2026-10-30
Exhibit 107 Calculation of Filing Fee Table Form S-1 (Form Type) N/A Exascale Labs Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Table 1-Newly Registered Securities Security Security Fee Amount Proposed Maximum Fee Amount Type Class Title …
Read attachment ↗exascalelabs_ex99-1.htm · 8-K · 2026-09-28
Exhibit 99.1 Exascale Labs Holdings Inc. Reports 111% Revenue Growth for Full Fiscal Year 2026 and Provides Business Update Following Successful Nasdaq Listing Fiscal year 2026 revenue increased 111% to $14.8 million, compared to $7.0 million in fiscal year 2025, driven by accelerating demand for the Company’s software-defined GPU-as-a-Service platform. Successfully completed business combination with D. Boral ARC Acquisition I Corp.; commenced trading on Nasdaq under ticker symbols “XLAB…
Read attachment ↗exascalelabs_ex99-1.htm · 8-K/A · 2026-09-28
Exhibit 99.1 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Audited Consolidated Financial Statements of Exascale Labs Inc.: Report of Independent Registered Public Accounting Firm (PCAOB ID: 7000) F-2 Consolidated Balance Sheets as of June 30, 2025 and 2026 F-3 Consolidated Statements of Operations and Comprehensive Loss for the years ended June 30, 2025 and 2026 F-4 Consolidated Statements of C…
Read attachment ↗exascalelabs_ex99-2.htm · 8-K/A · 2026-09-28
Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF EXASCALE LABS INC. The following discussion and analysis of the financial condition and results of operations of Exascale Labs Inc. (“Legacy Exascale”) for the years ended June 30, 2026 and 2025 is included as Exhibit 99.2 to Amendment No. 1 (the “Amendment”) to the Current Report on Form 8-K filed by Exascale Labs Holdings Inc. (“PubCo”) with the SEC on September 2, 2026 (the “Original Form …
Read attachment ↗exascalelabs_ex4-2.htm · 10-K · 2026-09-28
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of the date of the Annual Report on Form 10-K of which this exhibit is a part, Exascale Labs Holdings Inc. (the “Company,” “we,” “us” or “our”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) our Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), an…
Read attachment ↗exascalelabs_ex99-1.htm · 8-K · 2026-09-02
EX-99.1 9 exascalelabs_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction Capitalized terms used and not defined in this Exhibit shall have the meanings assigned to them in the Current Report on Form 8-K to which this Exhibit is attached. As previously disclosed, On January 11, 2026, BCAR, Exascale, PubCo and Merger Sub entered into the Business Combination Agreement. The Business Combination closed on August 27, 2026. BCAR is …
Read attachment ↗